About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Migraine and Endometriosis: The FEMININE Study | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT07519343

Migraine and Endometriosis: The FEMININE Study

Migraine and endometriosis are common conditions that mainly affect females of reproductive age. Both can cause significant pain and have a strong impact on the quality of life. Increasing evidence su...

Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Patricia Pozo-Rosich, Professor

CONTACT

+34 934 89 30 00 patricia.pozo@vallhebron.cat

Sponsors

Lead Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Adult females (≥18 years old).
•2. Diagnosis of migraine according to ICHD-3 criteria confirmed by a headache specialist (for MIG-O and MIG-EDM groups).
•3. Confirmed diagnosis of endometriosis based on clinical symptoms and imaging or surgical criteria according to ESHRE guidelines (for EDM-O and MIG-EDM groups).
•4. Signed informed consent.

Exclusion Criteria

•1. Individuals diagnosed with secondary headache according to the ICHD-3.
•2. Individuals with a severe disease (e.g., major psychiatric disorder, severe cardiovascular conditions).
•3. History of, treatment for, or evidence of, alcohol or drug abuse within the past 12 months.
•4. Pregnant or breastfeeding females.

Related studies

Chiropractic Care for Episodic Migraine

NCT06229834 · Episodic Migraine

ENDO1000 - A UK-wide Endometriosis Research Project

NCT07240883 · Endometriosis

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

BE WELL With Migraine: Brain Education and WELLness With Migraine

NCT05987592 · Migraine

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 9, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment150

Start dateJun 2026

Last updatedApr 9, 2026

Condition

Migraine Endometriosis

Locations shown

Vall d'Hebron University Hospital

Barcelona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions